Although a possible sex influence in the therapeutic effects of anti-TNFα compounds is controversial, a positive female sex influence was already reported in the prognosis of ulcerative colitis in patients treated with infliximab, an anti-TNFα monoclonal antibody (Nasuno et al., 2017). This evidence concerns the gene TNF and ulcerative colitis.